Gujarat Kidney & Super Speciality Ratios

Gujarat Kidney & Super Speciality Ltd Ratios

The Gujarat Kidney & Super Speciality Ltd Ratios page provides a complete fundamental analysis of Gujarat Kidney & Super Speciality Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Gujarat Kidney & Super Speciality Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Gujarat Kidney & Super Speciality Ltd (NSE: GKSL, BSE: 544666) is currently trading at ₹114.68, with a market capitalization of ₹9.09B. As a major player in the Health services sector and Hospital/Nursing management industry, Gujarat Kidney & Super Speciality Ltd remains a key stock for fundamental analysis using Gujarat Kidney & Super Speciality Ltd Ratios.

Gujarat Kidney & Super Speciality Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Gujarat Kidney & Super Speciality Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Gujarat Kidney & Super Speciality Ltd Ratios.

Historically, the Gujarat Kidney & Super Speciality Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The decline in Gujarat Kidney & Super Speciality Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Gujarat Kidney & Super Speciality Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Gujarat Kidney & Super Speciality Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Gujarat Kidney & Super Speciality Ltd P/S ratio currently stands at 0, an important part of Gujarat Kidney & Super Speciality Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Gujarat Kidney & Super Speciality Ltd P/S ratio indicates cautious market sentiment.

Gujarat Kidney & Super Speciality Ltd Price to Cash Flow Ratio (P/CF)

The Gujarat Kidney & Super Speciality Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Gujarat Kidney & Super Speciality Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The declining Gujarat Kidney & Super Speciality Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Gujarat Kidney & Super Speciality Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Gujarat Kidney & Super Speciality Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Gujarat Kidney & Super Speciality Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Gujarat Kidney & Super Speciality Ltd EV/EBITDA ratio is currently 0, a key metric in Gujarat Kidney & Super Speciality Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Gujarat Kidney & Super Speciality Ltd EV/EBITDA indicates balanced valuation.

Gujarat Kidney & Super Speciality Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Gujarat Kidney & Super Speciality Ltd D/E ratio is currently 0.32, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.32
• 2023: 0.54
• 2022: 0
• 2021: 0

Gujarat Kidney & Super Speciality Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Gujarat Kidney & Super Speciality Ltd ROE currently stands at 51.24%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 51.24
• 2023: 30.68
• 2022: -1.66
• 2021: 0

Gujarat Kidney & Super Speciality Ltd demonstrates strong profitability and efficient capital utilization.

Gujarat Kidney & Super Speciality Ltd Ratios Analysis Summary

The Gujarat Kidney & Super Speciality Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Gujarat Kidney & Super Speciality Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Gujarat Kidney & Super Speciality Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.